The Efficacy and Safety of Different Targeted Drugs for the Treatment of Generalized Myasthenia Gravis: A Systematic Review and Bayesian Network Meta-analysis Authors (first, second and last of 6) Yongbo Ma**angtao Nie**uming Guo Content type: Systematic Review Published: 01 February 2024 Pages: 93 - 104
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future Authors (first, second and last of 7) Salvatore CrisafulliBrigida BoccanegraAnnamaria De Luca Content type: Review Article Published: 11 January 2024 Pages: 15 - 32
Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use Authors Young-A Heo Content type: Adis Drug Q&A Open Access Published: 31 March 2023 Pages: 467 - 473
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study Authors (first, second and last of 14) Samuel FrankClaudia TestaThe Huntington Study Group/ARC-HD Investigators and Coordinators Content type: Original Research Article Open Access Published: 15 October 2022 Pages: 1207 - 1216
Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy Authors Hannah A. Blair Content type: Adis Drug Evaluation Published: 12 August 2022 Pages: 995 - 1005
Sodium Phenylbutyrate and Ursodoxicoltaurine: First Approval Authors Young-A Heo Content type: AdisInsight Report Published: 30 July 2022 Pages: 1007 - 1013
Risdiplam: A Review in Spinal Muscular Atrophy Authors Julia Paik Content type: Adis Drug Evaluation Published: 13 March 2022 Pages: 401 - 410
A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication Authors Adam StrzelczykSusanne Schubert-Bast Content type: Therapy in Practice Open Access Published: 14 February 2022 Pages: 217 - 237
Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine? Authors Meir BialerEmilio Perucca Content type: Leading Article Published: 30 January 2022 Pages: 113 - 122
Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic Model Authors (first, second and last of 10) Drew MacCannellZdenek BergerFrancesco Muntoni Content type: Original Research Article Open Access Published: 26 January 2022 Pages: 181 - 190
Nusinersen: A Review in 5q Spinal Muscular Atrophy Authors Sheridan M. Hoy Content type: Adis Drug Evaluation Open Access Published: 30 November 2021 Pages: 1317 - 1328
Pharmacotherapy for Seizures in Tuberous Sclerosis Complex Authors (first, second and last of 4) Rima NabboutMathieu KuchenbuchPaolo Curatolo Content type: Review Article Published: 21 August 2021 Pages: 965 - 983
Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients’ Perspectives Authors (first, second and last of 38) Laurent M. WillemsFelix RosenowAdam Strzelczyk Content type: Original Research Article Open Access Published: 17 July 2021 Pages: 1107 - 1122
Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis Authors (first, second and last of 8) Colin J. MahoneyRebekah M. AhmedMatthew C. Kiernan Content type: Review Article Published: 15 May 2021 Pages: 483 - 505
Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies Authors Adam StrzelczykSusanne Schubert-Bast Content type: Review Article Open Access Published: 21 January 2021 Pages: 61 - 83
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety Authors (first, second and last of 7) Simona LattanziFrancesco BrigoMauro Silvestrini Content type: Systematic Review Published: 10 February 2020 Pages: 229 - 241
Recent Advances in the Treatment of Huntington’s Disease: Targeting DNA and RNA Authors Kathleen M. Shannon Content type: LEADING ARTICLE Published: 13 January 2020 Pages: 219 - 228
Recent Advances in the Drug Treatment of Dravet Syndrome Authors Elaine C. WirrellRima Nabbout Content type: Review Article Published: 23 September 2019 Pages: 867 - 881
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials Authors (first, second and last of 9) Basil T. DarrasMichelle A. FarrarSarah Gheuens Content type: Original Research Article Open Access Published: 16 August 2019 Pages: 919 - 932
Long-Term Neuropsychological Outcomes from an Open-Label Phase I/IIa Trial of 2-Hydroxypropyl-β-Cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1 Authors (first, second and last of 6) Cristan A. FarmerAudrey ThurmForbes D. Porter Content type: Short Communication Published: 11 June 2019 Pages: 677 - 683
Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses Authors (first, second and last of 4) Alfried KohlschütterAngela SchulzStephan Storch Content type: Leading Article Open Access Published: 15 March 2019 Pages: 315 - 325
Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management Authors (first, second and last of 8) Thomas RegoSarah FarrandMark Walterfang Content type: Review Article Published: 10 January 2019 Pages: 125 - 142